News

December 15, 2020 (Clinical Researcher) Scientific and medical research is an investment in our future. We’re all keen to live long, healthy lives and most of us are willing to empower physicians [...]

November 10, 2020 (The Silicon Review) Cofactor Genomics is shortlisted in The Silicon Review’s 5 Best HealthTech Solution Providers to watch in 2020. See the listing and read more about [...]

October 19, 2020 (BioTechniques) Matching cancer patients to the therapies that provide the best chance of overcoming their disease is a difficult process, leading to a gap between the wealth of [...]

Contributed Commentary By Jarret Glasscock October 14, 2020 (DiagnosticsWorld) It has been said that the most dangerous phrase in business is, “We’ve always done it this way”. Believing that the [...]

September 23, 2020 (OncologyCentral) Title: Panel discussion: the past, present and future of immuno-oncology Duration: 1 hour This panel discussion, featuring experts from institutions across [...]

Industry Challenge Using precision medicine, researchers aim to find a new diagnostic approach for matching cancer patients with treatments and therapies based on multidimensional RNA models of [...]

SAN DIEGO, Calif.– SEPTEMBER 15, 2020 (Reportable) – Physicians at the University of California, San Diego (UCSD) School of Medicine and Cofactor Genomics, the company bridging the precision [...]

SAN FRANCISCO, September 9, 2020 (MedCityNews) – MedCity Influencers, Biopharma News By harnessing the combined power of NGS, machine learning and the dynamic nature of RNA we’re able to [...]

SAN FRANCISCO, Calif. – August 20, 2020 (Reportable) – Cofactor Genomics, the company bridging the precision medicine gap, announced today that the United States Patent and Trademark Office [...]

SAN FRANCISCO, July 23, 2020 (ClinicalOMICs) – Jarret Glasscock, CEO of Cofactor Genomics, recently spoke with Patrick Hurban, Senior Director and Global Head, Translational Genomics at [...]